Citation: Bi. Hirschowitz et al., Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study, ALIM PHARM, 15(11), 2001, pp. 1795-1806
Citation: Bi. Hirschowitz et Mm. Haber, Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole, ALIM PHARM, 15(1), 2001, pp. 87-103
Authors:
Lanas, A
Remacha, B
Sainz, R
Hirschowitz, BI
Citation: A. Lanas et al., Study of outcome after targeted intervention for peptic ulcer resistant toacid suppression therapy, AM J GASTRO, 95(2), 2000, pp. 513-519
Citation: Ke. Monkemuller et Bi. Hirschowitz, Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection, ALIM PHARM, 13(5), 1999, pp. 661-665